-
-
-
-
-
-
-
Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
-
-
-
-
-
-
-
Relmada Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
-
-
-
-
-
-
Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock
-
-
-
-
-
69,742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

